Zobrazeno 1 - 10
of 64
pro vyhledávání: '"A, Yuwono Soeroto"'
Autor:
Bintang Soetjahjo, Rusdy Ghazali Malueka, Arief Nurudhin, Purwoko, Sumardi, Rudi Wisaksana, Artrien Adhiputri, Sudadi, Arto Yuwono Soeroto, Brigitte Rina Aninda Sidharta, Jarir At Thobari, Tri Wahyu Murni, Widiastuti Soewondo, Elizabeth Henny Herningtyas, Reza Widianto Sudjud, Ika Trisnawati, Nur Rahmi Ananda, Ahmad Faried
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-12 (2023)
Abstract Inflammatory response in COVID-19 contributes greatly to disease severity. Mesenchymal Stem Cells (MSCs) have the potential to alleviate inflammation and reduce mortality and length of stay in COVID-19 patients. We investigated the safety an
Externí odkaz:
https://doaj.org/article/32173986629b4c3095857f1932f07529
Autor:
Bony Wiem Lestari, Gerine Nijman, Alamanda Larasmanah, Arto Yuwono Soeroto, Prayudi Santoso, Bachti Alisjahbana, Lidya Chaidir, Basti Andriyoko, Reinout van Crevel, Philip C. Hill
Publikováno v:
The Lancet Regional Health - Southeast Asia, Vol 22, Iss , Pp 100294- (2024)
Summary: Background: In Indonesia, drug resistance testing for TB largely relies on Xpert MTB/RIF, and it is unknown what proportion of drug-resistant (DR) TB is adequately diagnosed and treated. Methods: We conducted a cascade of care analysis on a
Externí odkaz:
https://doaj.org/article/07a384a50a2e46d4b6715864513851e9
Autor:
Maya Kusumawati, Raspati Cundarani Koesoemadinata, Zuhaira Husna Fatma, Evan Susandi, Hikmat Permana, Nanny Natalia Mulyani Soetedjo, Arto Yuwono Soeroto, Begawan Bestari, Basti Andriyoko, Bachti Alisjahbana, Yovita Hartantri
Publikováno v:
PLoS ONE, Vol 18, Iss 6, p e0286797 (2023)
Immune system dysregulation in people with diabetes mellitus (DM) increases the risk of acquiring severe infection. We compared the clinical characteristics and laboratory parameters of coronavirus disease 2019 (COVID-19) patients with and without DM
Externí odkaz:
https://doaj.org/article/2a3ed32d021740e29968fecc7cb73807
Publikováno v:
Althea Medical Journal, Vol 9, Iss 4 (2022)
Background: Diagnosis of drug-resistant tuberculosis (DR-TB) begins with identifying presumptive DR-TB patients using Xpert MTB/RIF, as a diagnostic test to detect resistance to rifampicin. The study aimed to identify the distribution of rifampicin-r
Externí odkaz:
https://doaj.org/article/fd8cf762f1ba480090e3c4e91942f989
Autor:
Prayudi Santoso, Henny Juliastuti, Heda Melinda Nataprawira, Arto Yuwono Soeroto, Bachti Alisjahbana, Rovina Ruslami, Josephine Debora, Yunia Sribudiani, Ani Melani Maskoen
Publikováno v:
Acta Medica Indonesiana, Vol 54, Iss 4 (2022)
Background: The blood level of rifampicin, one of the tuberculosis (TB) drugs, depends on the organic anion transporting polypeptide 1B1 (OATP1B1) in hepatocytes. This protein is encoded by the solute carrier organic anion 1B1 (SLCO1B1) gene. Its gen
Externí odkaz:
https://doaj.org/article/07e4c0206af140c38d846a6451abb856
Autor:
Amila Hanifan Muslimah, Marita Restie Tiara, Hofiya Djauhari, Muhammad Hafizh Dewantara, Evan Susandi, Agnes Rengga Indrati, Bachti Alisjahbana, Arto Yuwono Soeroto, Rudi Wisaksana
Publikováno v:
Vaccines, Vol 11, Iss 8, p 1300 (2023)
In August 2022, Indonesia prioritized healthcare workers to receive the second booster dose. We conducted a sequential serosurvey to understand the dynamics of the antibody titers. The first serosurvey, which was conducted in June 2021, 1–6 months
Externí odkaz:
https://doaj.org/article/b1d83eba710749c5acd4ae7536ac871d
Autor:
Arto Yuwono Soeroto, Raden Desy Nurhayati, Aga Purwiga, Bony Wiem Lestari, Chica Pratiwi, Prayudi Santoso, Iceu Dimas Kulsum, Hendarsyah Suryadinata, Ferdy Ferdian
Publikováno v:
PLoS ONE, Vol 17, Iss 1, p e0263304 (2022)
Background and aimsMulti drug or rifampicin resistant tuberculosis (MDR/RR-TB) is a major burden to TB prevention and eradication globally. Since 2016, WHO guidelines have included options for treating MDR/RR-TB with a standard regimen of 9 to 11 mon
Externí odkaz:
https://doaj.org/article/15d3662fb48b4b89ac04e2967ca70e6b
Publikováno v:
Jurnal Profesi Medika, Vol 15, Iss 0 (2021)
Coronavirus disease 2019 (COVID-19), which caused by SARS-COV-2, has spread globally. Pre-existing comorbidities such as diabetes, hypertension, cardiovascular disease, obesity, and malignancy may increase susceptibility to infection and the worsenin
Externí odkaz:
https://doaj.org/article/4acac2c824d340db9e1fbdcbd81cacd6
Publikováno v:
PLoS ONE, Vol 16, Iss 2, p e0246284 (2021)
BackgroundMultidrug-resistant tuberculosis had high treatment failure and mortality. Success rate of treatment currently 56% at global level, 48% in Indonesia and 36% in West Java province, the most populated province and surround Jakarta, the capito
Externí odkaz:
https://doaj.org/article/27c54967b9e4448293d1f70e7a40aaa6
Report of Two COVID-19 ARDS (CARDS) Cases Who Survived without Intubation and Mechanical Ventilation
Autor:
Arto Yuwono Soeroto, Yovita Hartantri, Jipi E Perkusi, Ferdy Ferdian, Undang Rehimat, Hendarsyah Suryadinata
Publikováno v:
Acta Medica Indonesiana, Vol 52, Iss 3 (2020)
The most severe clinical feature of COVID-19 is Acute Respiratory Distress Syndrome (ARDS) which requires intubation and mechanical ventilation and it occurs in approximately 2.3% of cases. About 94% of of these cases end in death. This case series r
Externí odkaz:
https://doaj.org/article/4a910569e30d47bdbbc077b61a101075